Enzo Biochem Inc. (ENZ)

3.29
0.15 4.40
NYSE : Health Technology
Prev Close 3.44
Open 3.44
Day Low/High 3.27 / 3.52
52 Wk Low/High 3.41 / 10.47
Volume 126.29K
Avg Volume 143.60K
Exchange NYSE
Shares Outstanding 47.18M
Market Cap 177.88M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Enzo Biochem Schedules Teleconference To Discuss Fourth Quarter And Fiscal 2018 Results Tuesday, October 16, 2018 At 8:30 AM E.T.

Enzo Biochem Schedules Teleconference To Discuss Fourth Quarter And Fiscal 2018 Results Tuesday, October 16, 2018 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 fourth quarter and year end results Tuesday, October 16, 2018, at 8:30 AM E.

Enzo Biochem To Acquire New Facility For Manufacturing And Distribution To Advance Its Diagnostic And Therapeutic Growth Strategy

Enzo Biochem To Acquire New Facility For Manufacturing And Distribution To Advance Its Diagnostic And Therapeutic Growth Strategy

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, announced today that, as part of implementing its growth strategy, it has entered into an agreement to purchase a commercial facility with nearly 36,000 square feet in...

Enzo Biochem Enters Oversold Territory (ENZ)

Enzo Biochem Enters Oversold Territory (ENZ)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Enzo Biochem Reports Validation Of Three High Quality, Low Cost Biomarkers For Detecting Cancers And Their Progression, Especially In Women's Health Area

Enzo Biochem Reports Validation Of Three High Quality, Low Cost Biomarkers For Detecting Cancers And Their Progression, Especially In Women's Health Area

Enzo Biochem Inc. (NYSE:ENZ) today announced the validation of three clinically relevant, cost-efficient biomarker detection tests for charting the progression of various cancers, especially in the field of women's health.

Enzo Biochem Is Now Oversold (ENZ)

Enzo Biochem Is Now Oversold (ENZ)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

RSI Alert: Enzo Biochem (ENZ) Now Oversold

RSI Alert: Enzo Biochem (ENZ) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Enzo Biochem Reports Third Quarter Results

Enzo Biochem Reports Third Quarter Results

Enzo Biochem Inc. (NYSE:ENZ), an integrated diagnostic company, today reported results for the third fiscal quarter and nine months ended April 30, 2018, in addition to noting significant progression of its strategic plan aimed at providing...

Enzo Biochem Schedules Teleconference To Discuss Third Quarter 2018 Results Tuesday, June 12, 2018 At 8:30 AM E.T.

Enzo Biochem Schedules Teleconference To Discuss Third Quarter 2018 Results Tuesday, June 12, 2018 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 third quarter results Tuesday, June 12, 2018, at 8:30 AM E.

Patent Trial And Appeal Board Denies Hologic Challenge To Enzo Biochem Patent Involved In Delaware Infringement Case

Patent Trial And Appeal Board Denies Hologic Challenge To Enzo Biochem Patent Involved In Delaware Infringement Case

Enzo Biochem, Inc. (NYSE:ENZ) and its subsidiary Enzo Life Sciences, Inc.

Relative Strength Alert For Enzo Biochem

Relative Strength Alert For Enzo Biochem

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Enzo Biochem Reports Second Quarter And First Half Results

Enzo Biochem Reports Second Quarter And First Half Results

Enzo Biochem Inc. (NYSE:ENZ) today announced results for the fiscal quarter and six months ended January 31, 2018.

Enzo Biochem Schedules Teleconference To Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 At 8:30 AM E.T.

Enzo Biochem Schedules Teleconference To Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 second quarter results Tuesday, March 13, 2018, at 8:30 AM E.

Enzo Biochem Becomes Oversold (ENZ)

Enzo Biochem Becomes Oversold (ENZ)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy Enzo Biochem At $5, Earn 9.2% Annualized Using Options

Commit To Buy Enzo Biochem At $5, Earn 9.2% Annualized Using Options

Investors eyeing a purchase of Enzo Biochem, Inc. stock, but tentative about paying the going market price of $6.72/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test

Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics company, announced today validation of a cervical cancer biomarker detection test that provides a highly robust and cost-efficient solution for anatomical pathology.

Enzo Biochem is Now Oversold (ENZ)

Enzo Biochem is Now Oversold (ENZ)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Enzo Biochem Reports Improved First Quarter Results

Enzo Biochem Reports Improved First Quarter Results

Enzo Biochem Inc. (NYSE:ENZ) today reported improved operating results for the first fiscal quarter ended October 31, 2017, including year over year double digit revenue growth at Enzo Clinical Labs.

Enzo Biochem Schedules Teleconference To Discuss First Quarter 2018 Results Friday, December 8, 2017 At 8:30 AM E.T.

Enzo Biochem Schedules Teleconference To Discuss First Quarter 2018 Results Friday, December 8, 2017 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 first quarter results Friday, December 8, 2017, at 8:30 AM E.

Closing out of a Biotech Position

Enzo Biochem has had some worrying action in price.

Doubling Down on This Biotech Name

Despite the earnings miss, this name has great promise -- and we are doubling our stake on this weakness.

Stocks Under $10 Weekly Summary

We exited two positions today following a tough week for small-cap stocks.

Relative Strength Alert For Enzo Biochem

Relative Strength Alert For Enzo Biochem

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Stocks Under $10 Weekly Summary

Last week, we increased our holdings in one position and added 2 Bullpen names.

Stocks Under $10 Weekly Summary

We used price declines to scale into several holdings as small-caps underperformed the overall market.

What Enzo Biochem's Good News Means for Our Position

Keep a close eye on this one, and establish a stop-loss order at or around $9.50.

Stocks Under $10 Weekly Summary

This week brings earnings from 5 portfolio holdings as the market continues to shrug off potential negatives.

Enzo Biochem Enters Oversold Territory (ENZ)

Enzo Biochem Enters Oversold Territory (ENZ)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Stocks Under $10 Weekly Summary

We took some profits and added a Bullpen name, among other moves, during a rough week for a few portfolio names.

TheStreet Quant Rating: D+ (Sell)